Clinical Trial
-
Recon
LimaCorporate Announces FDA Approval for an Ide Study on Smr Stemless Reverse Shoulder System
UDINE, Italy, Nov. 19, 2020 /PRNewswire/ — LimaCorporate is proud to announce that the U.S. Food and Drug Administration (FDA) has approved the…
Read More » -
Biologics
Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA
November 18, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…
Read More » -
Spine
One-Year Outcomes Data from the OptiMesh® SCOUT (Spineology® Clinical Outcomes Trial) IDE (Investigational Device Exemption) Published in SPINE
The OptiMesh® Expandable Interbody Fusion System demonstrates significant reduction in pain, improvement in back function, and high patient-satisfaction scores November 17,…
Read More » -
COVID-19
NYU Langone Health to Enroll Healthy Volunteers In Clinical Trial for COVID-19 Vaccine
NEW YORK, Nov. 11, 2020 /PRNewswire/ — NYU Grossman School of Medicine is among the centers enrolling participants in a randomized phase…
Read More » -
Extremities
Avanos Medical, Inc. Announces Publication of Clinical Trial Demonstrating Superiority of COOLIEF* over Hyaluronic Acid Injections for the Management of Chronic Knee Pain
ALPHARETTA, Ga., Sept. 3, 2020 /PRNewswire/ — Avanos Medical, Inc. (NYSE: AVNS) today announced the publication of a large, randomized, multicentered clinical trial comparing…
Read More » -
COVID-19
Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
NEW BRUNSWICK, N.J., July 30, 2020 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) (the Company) today announced that its lead vaccine candidate protected against…
Read More » -
Extremities
Mayo TJA Study: Mepivacaine=More Consistent Return of Motor Function Versus Low-Dose Bupivacaine
by Elizabeth Hofheinz, M.P.H., M.Ed. While spinal anesthesia confers benefits when administered during primary total hip arthroplasty (THA) and total…
Read More » -
Biologics
Cerapedics Announces FDA approval of an IDE supplement
WESTMINSTER, Colo., July 22, 2020 — Cerapedics, a private ortho-biologics company, today announced the U.S. Food and Drug Administration (FDA)…
Read More » -
Spine
Empirical Spine Completes Enrollment in Pivotal IDE Clinical Trial Studying LimiFlex in Degenerative Spondylolisthesis
SAN CARLOS, Calif., July 16, 2020 /PRNewswire/ — Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced completion of…
Read More » -
Extremities
CyMedica Orthopedics Completes e-vive Parent Clinical Trial for Management of Knee Osteoarthritis Pain
SCOTTSDALE, Ariz., June 16, 2020 CyMedica Orthopedics®, the leading combined muscle strengthening therapy and digital health innovator, announced today that…
Read More » -
COVID-19
Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19
June 11, 2020 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and…
Read More » -
COVID-19
Fauci ‘optimistic’ about coronavirus vaccine candidates, says early testing ‘looks quite promising’
June 10, 2020 / By Kayla Rivas | Fox News Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci said…
Read More » -
COVID-19
World Health Organization resumes coronavirus trial on malaria drug hydroxychloroquine after examining safety concerns
June 3, 2020 / Berkeley Lovelace Jr., William Feuer The World Health Organization is resuming its trial of hydroxychloroquine, the malaria…
Read More » -
COVID-19
Russians claim to have an effective treatment for the coronavirus, which hospitals will start using this month
June 1, 2020 / Holly Ellyatt Russia has approved an anti-influenza drug, Aviifavir, to treat Covid-19 and will start delivering…
Read More » -
Biologics
Cerapedics Announces Results from Clinical Trial of i-FACTOR® Peptide Enhanced Bone Graft in Lumbar Fusion Surgery
WESTMINSTER, Colo., May 19, 2020 /PRNewswire/ — Cerapedics, a private ortho-biologics company, today announced that results from a clinical trial evaluating i-FACTOR Peptide…
Read More »